Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAPKAPK2

RBC: MAPKAPK2 · Substrate: Glycogen Synthase-derived peptide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Asciminib15.30.60
Acalabrutinib13.30.67
Paxalisib12.20.61
Lapatinib11.50.62
Neratinib11.50.60
Ruxolitinib11.30.59
Ponatinib10.70.53
Gedatolisib10.40.61
Defactinib10.20.45
Brigatinib10.00.51
Pirtobrutinib9.80.66
Crizotinib9.80.58
Tenalisib9.40.70
Vemurafenib9.30.60
Idelalisib8.70.70

Known variants

No variants catalogued.
Open in new tab